Prognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience

Leuk Lymphoma. 2021 Sep;62(9):2272-2275. doi: 10.1080/10428194.2021.1907381. Epub 2021 Apr 2.

Authors

Juliette Pénichoux¹, Sydney Dubois¹, Daphné Krzisch¹, Anne-Lise Menard¹, Hélène Lanic¹, Vincent Camus¹, Emilie Lemasle¹, Stéphane Leprêtre¹, Pascal Lenain¹, Nathalie Contentin¹, Sylvie Daliphard², Gérard Buchonnet², Dominique Penther³, Christian Bastard³, Hervé Tilly¹, Fabrice Jardin¹, Aspasia Stamatoullas¹

Affiliations

¹ Department of Hematology, Centre Henri Becquerel, Rouen, France.
² Biological Hematology, Charles Nicolle University Hospital, Rouen, France.
³ Laboratoire de génétique oncologique, Centre Henri Becquerel, Rouen, France.

PMID: 33797310
DOI: 10.1080/10428194.2021.1907381

No abstract available

Publication types

Letter

MeSH terms

Humans
Lymphocytes
Monocytes*
Myelodysplastic Syndromes* / diagnosis
Prognosis
Retrospective Studies